Quick Answer: What Are the Warning Signs of Prostate Cancer?
Early prostate cancer usually causes no symptoms. That is the most important fact to understand. Many cancers are first detected because of PSA-based screening or evaluation of an abnormal prostate finding rather than because the man noticed a warning sign.
When prostate cancer does cause symptoms, possible signs can include a weak or slow urine stream, difficulty urinating, blood in the urine or semen, erectile problems, or persistent pain in the back, hips or pelvis. These symptoms are more often caused by non-cancerous conditions such as BPH, prostatitis or urinary infection, so symptoms alone cannot diagnose prostate cancer.
Advanced prostate cancer can spread to bone and, rarely, compress the spinal cord. New leg weakness or numbness, difficulty walking, or loss of bladder or bowel control together with back pain requires urgent medical assessment.
Why Prostate Cancer Often Has No Early Warning Signs
Localized prostate cancer commonly grows in the outer part of the prostate, away from the urethra. A small tumor can therefore be present without interfering with urine flow.
The National Cancer Institute states that early-stage prostate cancer does not usually cause symptoms. This is why waiting for urinary problems is not a reliable early-detection strategy.
Symptoms are changes a person notices. Screening means looking for cancer before symptoms develop. For prostate cancer, the PSA blood test is the principal first-line screening test when screening is appropriate.
Possible Prostate Cancer Symptoms
Although early disease is often silent, prostate cancer can sometimes cause symptoms as it grows.
Urinary Changes
Possible urinary symptoms include:
- difficulty starting urination;
- a weak or slow urine stream;
- needing to urinate more frequently;
- waking repeatedly at night to urinate;
- difficulty emptying the bladder; and
- blood in the urine.
However, these symptoms are far more commonly caused by benign prostate enlargement (BPH) or another urinary condition.
BPH does not turn into prostate cancer. The two conditions can simply occur in the same man, particularly because both become more common with age.
Blood in the Semen
Blood in semen can occur with prostate cancer, but it is not specific for cancer. Inflammation, infection, recent prostate procedures and other benign conditions can also cause hematospermia.
Persistent or recurrent blood in the semen should be discussed with a clinician, especially in an older man or when accompanied by other concerning findings.
Erectile Dysfunction
Difficulty achieving or maintaining an erection may occur in men with advanced prostate cancer, but erectile dysfunction is extremely common for many non-cancer reasons, including vascular disease, diabetes, medications and age-related changes.
ED alone should therefore not be interpreted as evidence of prostate cancer.
Persistent Pelvic, Hip or Back Pain
Persistent pain in the hips, spine, ribs or other bones can occur when advanced prostate cancer has spread to bone.
Ordinary back pain is very common and is usually caused by musculoskeletal conditions, but persistent unexplained pain—particularly when combined with weight loss, weakness or a known prostate-cancer diagnosis—needs medical evaluation.
Read more about prostate cancer metastasis and prostate cancer stages.
Advanced Warning Signs That Need Prompt Attention
Advanced prostate cancer can cause symptoms according to where it has spread.
| Possible symptom | Why it matters |
|---|---|
| Persistent bone pain | Prostate cancer commonly spreads to bone when metastatic, although most bone pain has other causes. |
| Unexplained weight loss or marked fatigue | Can occur with advanced cancer but is nonspecific. |
| Leg weakness or numbness | Can signal spinal-cord or nerve-root compression from spinal metastases. |
| New loss of bladder or bowel control | May indicate spinal-cord compression and requires urgent assessment. |
| Difficulty walking with severe back pain | Another neurological red flag for possible spinal involvement. |
Symptoms That Are Often Mistaken for Prostate Cancer
Several common prostate and urinary problems overlap with possible cancer symptoms.
BPH
BPH symptoms commonly include weak flow, hesitancy, frequency, urgency, nocturia and incomplete emptying.
These urinary symptoms are generally much more likely to be caused by BPH than by early prostate cancer.
Prostatitis
Prostatitis and chronic pelvic pain can cause burning urination, pelvic or perineal pain, painful ejaculation, urinary frequency and sometimes fever.
These symptoms can be distressing, but they do not mean cancer is present.
Urinary Tract Infection
Burning, urgency, frequency, cloudy urine and fever can occur with urinary infection. In men, persistent urinary symptoms should be properly evaluated rather than self-diagnosed as either BPH or prostate cancer.
Who Has a Higher Risk of Prostate Cancer?
Risk is not the same as a warning sign, but it helps determine when screening discussions should begin.
Established risk factors include:
- increasing age — risk rises substantially after age 50;
- Black ancestry — associated with higher incidence and a higher risk of serious disease;
- strong family history — particularly prostate cancer in close relatives at younger ages; and
- certain inherited genetic variants, including mutations such as BRCA2 and some DNA-repair genes.
A man can have prostate cancer without any of these additional risk factors.
Should Every Man Have an Annual Prostate Check From Age 45?
No. The old version of this article recommended mandatory annual testing from age 45. Current guidance is more individualized.
The 2026 AUA/SUO early-detection guideline continues a risk-adapted, shared-decision approach:
- clinicians may offer a baseline PSA between ages 45 and 50 to people at average risk;
- screening should be offered earlier, around age 40–45, to people at increased risk because of Black ancestry, a strong family history or relevant germline mutations; and
- for people aged 50–69 who choose screening, regular PSA screening every 2–4 years is recommended, with the interval personalized according to PSA, risk and preferences.
The American Cancer Society uses a slightly different discussion framework: age 50 for average-risk men with at least a 10-year life expectancy, age 45 for higher-risk men, and age 40 for those at very high risk.
Is the IPSS Symptom Score a Prostate Cancer Test?
No.
The International Prostate Symptom Score (IPSS), historically related to the AUA Symptom Index, measures the severity of lower urinary tract symptoms.
It is useful in evaluating and following men with BPH/LUTS.
It is not a prostate-cancer screening test, diagnostic test or validated cancer prognostic tool.
What Is the First Screening Test for Prostate Cancer?
Current AUA/SUO guidance recommends the PSA blood test as the first screening test.
PSA is produced by normal and malignant prostate cells. An elevated PSA can occur because of:
- prostate cancer;
- BPH;
- prostatitis or inflammation;
- urinary retention;
- recent prostate or urinary procedures; and
- other temporary influences.
Therefore, an elevated PSA is not itself a cancer diagnosis.
Read our detailed PSA guide.
What Happens if PSA Is Elevated?
An abnormal result should not automatically lead straight to biopsy.
The AUA/SUO guideline recommends repeating a newly elevated PSA before proceeding to secondary biomarkers, imaging or biopsy because PSA can normalize on repeat testing.
If PSA remains concerning, the next steps may incorporate:
- age and overall health;
- family history and ancestry;
- digital rectal examination;
- PSA density and percent-free PSA;
- validated prostate-cancer risk calculators;
- secondary blood or urine biomarkers in selected men; and
- multiparametric prostate MRI.
What Is the Role of Digital Rectal Examination?
DRE can identify prostate nodules, induration, asymmetry or other suspicious findings.
However, current AUA guidance says that DRE should not be used as the sole prostate-cancer screening test.
PSA is the principal first-line screening test. DRE may be added to help refine risk, particularly when PSA is elevated or there are concerning clinical findings.
Is Ultrasound the “Hallmark” Test Before Biopsy?
No.
Ordinary prostate ultrasound can estimate prostate size and is useful in several urological settings, but it is not the principal modern test for finding clinically significant prostate cancer.
Multiparametric MRI now plays a major role in risk assessment and biopsy planning.
The 2026 AUA/SUO guideline amendment strengthened the evidence supporting MRI before an initial prostate biopsy to improve detection of clinically significant Grade Group 2 or higher cancer.
Does an Abnormal PSA or MRI Confirm Cancer?
No.
A PSA, DRE, biomarker test or MRI can estimate the likelihood of cancer, but prostate tissue obtained by biopsy is generally required to make a histologic diagnosis.
When biopsy is appropriate, MRI can help identify suspicious lesions for targeted sampling.
Learn more in our prostate testing guide.
Does Prostate Biopsy Spread Cancer?
This is another important correction from the older site content.
Modern prostate biopsy is a standard diagnostic procedure. The theoretical phenomenon of tumor seeding along a needle tract is extraordinarily rare and is not a reason to avoid a clinically indicated prostate biopsy.
The real biopsy considerations include temporary bleeding, discomfort, urinary retention and infection risk. Modern transperineal biopsy techniques can reduce infectious complications in appropriate settings.
Should Doctors Give Antibiotics First and Biopsy Only if Symptoms Continue?
No—not as a general prostate-cancer diagnostic strategy.
An asymptomatic man with an elevated PSA should not routinely receive antibiotics simply to see whether PSA falls.
If there is genuine evidence of bacterial urinary infection or bacterial prostatitis, that infection should of course be treated. But urinary symptoms, PSA testing and prostate-cancer risk should then be reassessed appropriately.
Does Finding Prostate Cancer Early Always Mean Immediate Treatment?
No.
This is another important modern distinction.
Some localized prostate cancers are biologically low risk and may never cause symptoms or shorten life. For appropriately selected men with low-risk disease, active surveillance is often the preferred strategy rather than immediate surgery or radiation.
Other prostate cancers are clinically significant and benefit from timely treatment.
The purpose of modern early detection is therefore not simply to find every prostate-cancer cell—it is to identify cancers that are likely to matter while reducing unnecessary diagnosis and treatment of indolent disease.
What Should You Do if You Notice a Possible Warning Sign?
- Do not panic. Most urinary and sexual symptoms have causes other than prostate cancer.
- Arrange a medical assessment if the symptom persists, recurs or is unexplained.
- Tell the clinician about family history, ancestry, previous PSA values and any genetic cancer history.
- Have appropriate urinary testing when infection, blood in the urine or another urinary condition is possible.
- Discuss PSA testing when appropriate for your age, risk and symptoms.
- If PSA is newly elevated, confirm the result before assuming cancer.
- If risk remains concerning, discuss MRI, biomarkers, risk calculators and biopsy with a urologist.
When Should You Seek Prompt or Urgent Medical Care?
- visible blood in the urine that persists or is heavy;
- complete inability to urinate;
- fever or chills with severe urinary symptoms;
- persistent unexplained bone or back pain;
- rapidly worsening weakness or weight loss; or
- new neurological symptoms such as leg weakness, numbness, difficulty walking, or loss of bladder/bowel control.
The Most Important Takeaway
When men ask me about the “first symptom” of prostate cancer, I explain that there often is no first symptom. Early prostate cancer is frequently silent.
Urinary symptoms such as weak flow and nighttime urination are much more often caused by BPH. Burning and pelvic pain may suggest infection or prostatitis. Blood in urine or semen and persistent pain deserve investigation, but none of these symptoms can diagnose prostate cancer by themselves.
The safest approach is to combine symptom awareness with age- and risk-appropriate PSA screening. If PSA is abnormal, modern evaluation usually confirms the result and then uses the overall risk profile, potentially including MRI and other tests, before deciding whether biopsy is necessary.
Dr. Albana Greca, MD, MMedSc
Family Physician / General Practitioner
Founder & Lead Medical Author, Prostate Treatment Options
Medical References
American Urological Association / Society of Urologic Oncology. Early Detection of Prostate Cancer Guideline, 2023; amended 2026. PSA-first screening, risk-adapted screening, repeat testing of newly elevated PSA, DRE as an adjunct, MRI and biopsy guidance.
Lin DW, et al. Updates to Early Detection of Prostate Cancer: AUA/SUO Guideline (2026). Journal of Urology. 2026;215(5):491–501.
National Cancer Institute. Understanding Prostate Changes; Prostate-Specific Antigen (PSA) Test; Prostate Cancer Screening.
American Cancer Society. Prostate Cancer Signs and Symptoms; Recommendations for Prostate Cancer Early Detection.
Last evidence update: September 2026.
Medical information notice: This article is for general education and does not replace personal medical evaluation. Symptoms that may occur with prostate cancer are often caused by other conditions, and prostate cancer can also be present without symptoms.